Skip to main content
Matthias Holdhoff, MD, Oncology, Baltimore, MD

Matthias Holdhoff MD

Hematologic Oncology, Neuro-Oncology


Associate Professor of Oncology, Associate Professor of Neurological Surgery, Johns Hopkins University School of Medicine

Join to View Full Profile
  • 201 North Broadway StreetViragh BLDG 5th FLBaltimore, MD 21287

  • Phone+1 410-955-8964

  • Fax+1 410-367-2194

Dr. Holdhoff is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2007 - 2010
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 2004 - 2007
  • Freie University Berlin Faculty of Medicine
    Freie University Berlin Faculty of MedicineClass of 2003

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2024 - Present
  • DC State Medical License
    DC State Medical License 2013 - 2026
  • MD State Medical License
    MD State Medical License 2007 - 2026
  • PA State Medical License
    PA State Medical License 2024 - 2026
  • VA State Medical License
    VA State Medical License 2023 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • A Multiprotein Supercomplex Controlling Oncogenic Signalling in Lymphoma  
    Maryknoll M Palisoc, Lisa M Rimsza, Stephen M Hewitt, Wyndham H Wilson, Matthias Holdhoff, Fayez Estephan, Nature

Abstracts/Posters

  • Reponse-Adapted Study of Ibrutinib with Temozolomide, Etoposide, Doxil, Dexamethasone, and Rituximab (TEDDI-R) in Aggressive B-Cell Lymphomas with Secondary Involvemen...
    Matthias Holdhoff, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

  • Doctors Still Seeking Cure for Brain Cancer That Struck Former Utah Rep. Mia Love
    Doctors Still Seeking Cure for Brain Cancer That Struck Former Utah Rep. Mia LoveMarch 25th, 2025
  • FDA Approves Drug That Targets Brain Cancer Gene Mutation That Could Delay Need for Radiation and Chemotherapy
    FDA Approves Drug That Targets Brain Cancer Gene Mutation That Could Delay Need for Radiation and ChemotherapyAugust 17th, 2024
  • Lantern Pharma to Host Virtual KOL Event on Glioblastoma Multiforme (GBM) with Collaborators from Johns Hopkins During Brain Tumor Awareness Month
    Lantern Pharma to Host Virtual KOL Event on Glioblastoma Multiforme (GBM) with Collaborators from Johns Hopkins During Brain Tumor Awareness MonthMay 12th, 2022
  • Join now to see all

Grant Support

  • Cell-free DNA-Based Analysis for Diagnosis, Monitoring and Optimization of Therapy for Patients with Primary Central Nervous System LymphomasJOHNS HOPKINS UNIVERSITY2022–2025

Other Languages

  • German, French

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: